Bulletin
Investor Alert

Tilray Inc. Cl 2

NAS: TLRY

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Mar 27, 2020, 7:59 p.m.

/zigman2/quotes/209129655/composite

$

8.82

Change

-0.28 -3.08%

Volume

Volume 465,238

Quotes are delayed by 20 min

/zigman2/quotes/209129655/composite

Previous close

$ 7.90

$ 9.10

Change

+1.20 +15.19%

Day low

Day high

$8.50

$10.60

Open

52 week low

52 week high

$2.43

$66.40

Open

Insider Actions for Tilray Inc. Cl 2

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
03/18/2020 Andrew Pucher
Chief Corporate Dev Officer
16,072   Derivative/Non-derivative trans. at $2.47 per share. 39,697
03/18/2020 Andrew Pucher
Chief Corporate Dev Officer
30,024   Derivative/Non-derivative trans. at $0 per share. 0
03/01/2020 Maryscott Greenwood
Director
2,187   Derivative/Non-derivative trans. at $0 per share. 0
03/01/2020 Rebekah Dopp
Director
2,187   Derivative/Non-derivative trans. at $0 per share. 0
03/01/2020 Christine Thompson St. Clare
Director
2,187   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Brendan Kennedy
President and CEO; Director
100,000   Disposition at $16.28 per share. 1,628,000
02/13/2020 Brendan Kennedy
President and CEO; Director
100,000   Derivative/Non-derivative trans. at $7.76 per share. 776,000
01/13/2020 Brendan Kennedy
President and CEO; Director
3,294   Disposition at $17.34 per share. 57,117
01/13/2020 Brendan Kennedy
President and CEO; Director
67,113   Disposition at $16.74 per share. 1,123,471
01/13/2020 Brendan Kennedy
President and CEO; Director
29,593   Disposition at $15.52 per share. 459,283
01/01/2020 Brendan Kennedy
President and CEO; Director
13,899   Derivative/Non-derivative trans. at $17.13 per share. 238,089
01/01/2020 Edward Wood Pastorius
Chief Revenue Officer
2,135   Derivative/Non-derivative trans. at $17.13 per share. 36,572
01/01/2020 Brendan Kennedy
President and CEO; Director
46,875   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2020 Michael Shtender-Auerbach
Director
2,187   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2020 Edward Wood Pastorius
Chief Revenue Officer
6,250   Derivative/Non-derivative trans. at $0 per share. 0
12/12/2019 Michael Shtender-Auerbach
Director
2,130,577   Award at $0 per share. 0
12/12/2019 Michael Shtender-Auerbach
Director
833,351   Award at $0 per share. 0
12/12/2019 Michael Shtender-Auerbach
Director
476,641   Award at $0 per share. 0
12/12/2019 Edward Wood Pastorius
Chief Revenue Officer
41,015   Award at $0 per share. 0
12/12/2019 Edward Wood Pastorius
Chief Revenue Officer
49,985   Award at $0 per share. 0
12/12/2019 Edward Wood Pastorius
Chief Revenue Officer
61,729   Award at $0 per share. 0
12/11/2019 Brendan Kennedy
President and CEO; Director
100,000   Disposition at $18.3 per share. 1,830,000
12/02/2019 Michael Shtender-Auerbach
Director
900   Disposition at $19.81 per share. 17,829
12/02/2019 Michael Shtender-Auerbach
Director
7,537   Disposition at $19.05 per share. 143,579
12/02/2019 Michael Shtender-Auerbach
Director
31,875   Disposition at $19.05 per share. 607,218
12/02/2019 Michael Shtender-Auerbach
Director
18,750   Derivative/Non-derivative trans. at $7.76 per share. 145,500
12/01/2019 Maryscott Greenwood
Director
2,188   Derivative/Non-derivative trans. at $0 per share. 0
12/01/2019 Rebekah Dopp
Director
2,188   Derivative/Non-derivative trans. at $0 per share. 0
12/01/2019 Christine Thompson St. Clare
Director
2,188   Derivative/Non-derivative trans. at $0 per share. 0
10/01/2019 Brendan Kennedy
President and CEO; Director
18,461   Derivative/Non-derivative trans. at $24.18 per share. 446,386
10/01/2019 Edward Wood Pastorius
Chief Revenue Officer
2,749   Derivative/Non-derivative trans. at $24.18 per share. 66,470
10/01/2019 Brendan Kennedy
President and CEO; Director
46,875   Derivative/Non-derivative trans. at $0 per share. 0
10/01/2019 Michael Shtender-Auerbach
Director
2,188   Derivative/Non-derivative trans. at $0 per share. 0
10/01/2019 Edward Wood Pastorius
Chief Revenue Officer
6,250   Derivative/Non-derivative trans. at $0 per share. 0

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
8 Purchases
7 Sales
191,897
232,106
Last 6 months
21 Purchases
13 Sales
3,865,822
393,628
Last 12 months
37 Purchases
29 Sales
4,319,570
664,206

Officers and Executives

Mr. Brendan Kennedy
President, Chief Executive Officer & Director
Mr. Jon Levin
Chief Operating Officer
Mr. Michael Kruteck
Chief Financial Officer
Mr. Cuba Flowers
Chief Information Officer
Dr. Joshua Eades
Chief Science Officer & Vice President
Ms. Kristina Adamski
Executive Vice President-Corporate Affairs
Mr. Mark Castaneda
Head-Strategic Business Development
Mr. John Andonoff
SVP-Global Medical Sales Development
Mr. Andrew Pucher
Chief Corporate Development Officer
Mr. Greg Christopher
Executive Vice President-Operations
Mr. Charlie Cain
Vice President-Retail
Mr. Edward Wood Pastorius
Chief Revenue Officer
Mr. Michael B. Auerbach
Director
Ms. Adine Fabiani-Carter
Chief Marketing Officer
Ms. Rita Seguin
Executive Vice President-Human Resources
Ms. Dara Redler
Secretary & General Counsel
Ms. Catherine Jacobson
VP-Regulatory & Medical Affairs
Ms. Christine Thompson St. Clare
Independent Director
Ms. Maryscott Greenwood
Independent Director
Ms. Rebekah Dopp
Independent Director
Mr. Michael Shtender-Auerbach
Independent Director
Link to MarketWatch's Slice.